Ventyx Biosciences, Inc. Profile Avatar - Palmy Investing

Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that i…

Biotechnology
US, Encinitas [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Ventyx Biosciences, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Ventyx Biosciences, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Ventyx Biosciences, Inc..

End of VTYX's Analysis
CIK: 1851194 CUSIP: 92332V107 ISIN: US92332V1070 LEI: - UEI: -
Secondary Listings
VTYX has no secondary listings inside our databases.